These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2181892)

  • 1. [Platelet antiaggregants in the treatment of vasculopathies].
    Honorato J; Montes-Jovellar B
    Angiologia; 1990; 42(1):1-10. PubMed ID: 2181892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet antiaggregants in the treatment of arterial thrombosis].
    Ferlito S
    Minerva Cardioangiol; 1991 Oct; 39(10):375-89. PubMed ID: 1803283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet drugs in arterial thrombosis: a review.
    Tsu EC
    Am J Hosp Pharm; 1978 Dec; 35(12):1507-15. PubMed ID: 362914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute complications of coronary angioplasty: prevention and management].
    Bonnet JL; Avran A; Quilici J; Fourcade L; Bory M
    Arch Mal Coeur Vaiss; 1999 Nov; 92(11 Suppl):1571-8. PubMed ID: 10598237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombogenicity in patients with percutaneous coronary artery intervention and dual antiplatelet treatment.
    Kamphuisen PW
    Eur Heart J; 2008 Jul; 29(14):1699-700. PubMed ID: 18544543
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current approach in antithrombotic treatment during coronary interventions: specific thrombocyte aggregation inhibitors and direct thrombin antagonists in high-risk patients].
    Meyer BJ
    Schweiz Med Wochenschr; 1996 Nov; 126(46):1961-9. PubMed ID: 8984604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
    Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
    Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular disease: medical therapy, surgery and interventional technologies.
    Korr KS
    Med Health R I; 2008 Oct; 91(10):300. PubMed ID: 19044103
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization procedures.
    Dangas G; Fuster V
    Rev Port Cardiol; 1999 Feb; 18 Suppl 1():I49-53. PubMed ID: 10191675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
    Jessup DB; Coletti AT; Muhlestein JB; Barry WH; Shean FC; Whisenant BK
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):180-4. PubMed ID: 14517922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
    Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
    G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy--Part I.
    Goodnight SH; Coull BM; McAnulty JH; Taylor LM
    West J Med; 1993 Apr; 158(4):385-92. PubMed ID: 8317125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioplasty in severe heart attack. Anesthesia and general management.
    Ranucci M
    Minerva Anestesiol; 2002 Apr; 68(4):192-5. PubMed ID: 12024081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of GPIIb/IIIa inhibitors in cardiovascular medicine.
    Ahrens I; Peter K; Bode C
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):233-42. PubMed ID: 15030283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [-New aspects in antithrombotic therapy--platelet inhibitors-].
    Terres W; Meinertz T
    Herz; 1996 Feb; 21(1):1-11. PubMed ID: 8647575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulants, platelet antiaggregants after aortocoronary bypass?].
    Nicolas G
    Ann Cardiol Angeiol (Paris); 1990 Dec; 39(10):613-6. PubMed ID: 2291614
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty.
    Sakuma T; Sari I; Goodman CN; Lindner JR; Klibanov AL; Kaul S
    Cardiovasc Res; 2005 Jun; 66(3):552-61. PubMed ID: 15914120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.
    Hochholzer W; Trenk D; Bestehorn HP; Fischer B; Valina CM; Ferenc M; Gick M; Caputo A; Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2006 Nov; 48(9):1742-50. PubMed ID: 17084243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.